Arkolith/Insider Trading/IONS/Form 4

Baroldi Joseph

EVP, Chief Business OfficerIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$452K
Net Open-Market Flow
-$452K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)4K$56.78$220K9K
Jun 26, 2026Option exercise(M)2K$32.60$58K10K
Jun 26, 2026Sell(S)6K$80.16$452K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)2K—$00
Jun 26, 2026Option exercise(M)4K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000218) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML